A sterile room (or cleanroom for aseptic processing) is a controlled environment designed to minimize microbial and particulate contamination, ensuring that products such as injectable drugs, implants, and sterile medical devices remain free of viable microorganisms. Unlike general cleanrooms, a sterile room must meet stringent requirements for microbiological control, often governed by regulatory bodies like the FDA, EMA, and WHO. This article provides a deep technical exploration of sterile room principles, including design, validation, operation, and industry best practices. Leading engineering firms like TAI JIE ER specialize in delivering turnkey sterile rooms that comply with international GMP standards.
A sterile room is not merely a very clean room; it must demonstrate that the probability of microbial contamination is acceptably low. The primary standards for classification are ISO 14644‑1 (particulate cleanliness) and EU GMP Annex 1 (microbial limits for aseptic manufacturing).
ISO 5 (Class 100) – Required for critical zones where sterile products are exposed (e.g., filling lines, stopper bowls). Allows ≤3,520 particles ≥0.5 µm/m³.
ISO 7 (Class 10,000) – Background environment for ISO 5 zones, typically used for buffer rooms and changing rooms. Allows ≤352,000 particles ≥0.5 µm/m³.
ISO 8 (Class 100,000) – Less critical areas, such as gowning rooms and corridors leading to sterile areas.
Grade A – Local zone for high‑risk operations (e.g., filling). Equivalent to ISO 5 in operation, with strict microbial limits (≤1 CFU/m³).
Grade B – Background environment for Grade A (usually ISO 5 at rest, ISO 7 in operation).
Grade C – Clean areas for less critical steps (ISO 7 at rest, ISO 8 in operation).
Grade D – General clean areas (ISO 8 at rest).
Design of a sterile room must consider both at‑rest and in‑operation conditions, with validation proving that microbial and particle counts remain below limits under normal working conditions.
Creating a sterile environment requires an integrated approach to architecture, HVAC, and material selection.
The heating, ventilation and air conditioning (HVAC) system is the backbone of any sterile room. Key features include:
HEPA/ULPA filters – Terminal HEPA filters (H14 grade, ≥99.995% efficient at MPPS) supply air to critical zones. For Grade A areas, unidirectional (laminar) airflow is required, typically at 0.36–0.54 m/s.
Air change rates – Grade A zones often have 300–600 air changes per hour (ACH) to maintain cleanliness; Grade B may have 40–60 ACH.
Temperature and humidity control – Typically 20–24 °C and 35–55% RH, with tolerances of ±2 °C and ±10% RH to ensure operator comfort and product stability.
Positive pressure differentials (typically 10–15 Pa) between cleaner and dirtier areas prevent ingress of contaminated air. Airlocks (personnel and material) are designed with interlocked doors to maintain pressure cascades. Three common airlock types are:
Cascade airlock – Higher pressure on the clean side, lower on the dirty side.
Pressure bubble – High pressure in the airlock itself, protecting both adjacent areas.
Pressure sink – Low pressure in the airlock to contain hazardous materials (e.g., potent compounds).
All surfaces must be smooth, non‑porous, resistant to disinfectants, and easy to clean. Common choices include:
Epoxy or polyurethane seamless floors with coved corners.
Modular wall panels with baked enamel or stainless steel (316L) finishes.
PVC or vinyl wall coverings with heat‑welded seams.
Flush‑mounted lighting and utility penetrations sealed with silicone.
TAI JIE ER provides modular sterile room systems with pre‑finished panels that meet these stringent requirements and accelerate construction timelines.
Even the best‑designed sterile room will fail without rigorous operational controls.
Humans are the primary source of contamination. Strict protocols include:
Full coverage gowning: sterile coveralls, hoods, face masks, goggles, sterile gloves, and boots.
Gowning qualification: periodic microbial sampling of gown surfaces (contact plates).
Behavioral restrictions: slow movements, no talking over exposed product, minimal personnel in critical zones.
All items entering the sterile room must be decontaminated. Common methods:
Pass‑through autoclaves for heat‑stable items.
Vaporized hydrogen peroxide (VHP) chambers for heat‑sensitive components.
Wipe‑down with sporicidal disinfectants for large equipment.
A validated cleaning program is essential. It typically includes:
Daily cleaning with detergent followed by disinfectant (e.g., 70% IPA, quaternary ammonium compounds).
Weekly or monthly rotation with sporicidal agents (e.g., peracetic acid, chlorine dioxide) to eliminate resistant spores.
Use of sterile, low‑lint wipes and mops; all solutions are filtered (0.2 µm) before use.
Validation demonstrates that the sterile room consistently operates within defined parameters. It is divided into installation qualification (IQ), operational qualification (OQ), and performance qualification (PQ).
HEPA filter integrity – Scanning with a photometer or particle counter to detect leaks (tested annually or after filter change).
Airflow velocity and uniformity – Measured at working height for unidirectional zones.
Pressure differentials – Continuous monitoring with alarms.
Particle counts – Performed at rest and in operation according to ISO 14644‑1.
Settle plates – Exposed for a defined time (typically 4 hours) to capture viable particles settling on surfaces.
Active air sampling – Using impaction or filtration samplers to quantify airborne CFU/m³.
Surface sampling – Contact plates or swabs on critical surfaces (walls, equipment, gowns).
Personnel monitoring – Glove and gown impression plates after aseptic operations.
For sterile manufacturing, media fills are performed using a microbiological growth medium in place of the product. The entire process – including interventions, shifts, and worst‑case conditions – is simulated. Acceptance criteria: zero contaminated units from a statistically valid batch size.
Sterile room technology is vital in several sectors:
Pharmaceutical manufacturing – Aseptic filling of injectables, ophthalmic solutions, and biologics. Compliance with EU GMP and FDA 21 CFR is mandatory.
Biotechnology – Cell therapy production, vaccine filling, and gene therapy vectors require ISO 5 environments with stringent microbial control.
Medical devices – Assembly of sterile implants, catheters, and surgical kits under ISO 7 conditions, followed by terminal sterilization.
Hospital pharmacies – Compounding of sterile preparations (e.g., IV admixtures, chemotherapy) in cleanrooms that meet USP 797/800 standards.
Maintaining a sterile room involves overcoming persistent operational hurdles.
Despite rigorous gowning, human error remains the leading cause of microbial excursions. Solutions include:
Automated gowning verification systems (e.g., particle counters at exit).
Real‑time location systems (RTLS) to track personnel movement and prevent overcrowding.
Continuous training and re‑qualification every 6–12 months.
Overuse of a single disinfectant can lead to resistant strains. A rotation program with different modes of action (oxidative, oxidative, and alcohol‑based) is recommended. Efficacy must be validated against isolates from the facility.
Sterile rooms require high air change rates and 24/7 operation, leading to significant energy costs. Mitigation strategies:
Energy recovery wheels to capture cooling from exhaust air.
Variable air volume (VAV) systems with setback during unoccupied periods (while maintaining pressure cascades).
Use of high‑efficiency EC fans and low‑pressure‑drop HEPA filters.
Recent revisions to EU GMP Annex 1 (2022) place greater emphasis on contamination control strategies (CCS), risk assessment, and the use of isolators. Facilities must adapt by upgrading HVAC controls and monitoring systems. TAI JIE ER offers gap analysis and retrofit services to ensure compliance with the latest standards.
Isolators and restricted access barrier systems (RABS) – These reduce human intervention in critical zones, lowering contamination risk and allowing lower grades in surrounding areas.
Continuous monitoring with IoT – Wireless sensors for real‑time particle, temperature, and humidity data, integrated with building management systems (BMS) and alerting.
Single‑use systems – Pre‑sterilized disposable components (bags, tubing, connectors) reduce cleaning validation and contamination risk.
Modular sterile rooms – Prefabricated, scalable units that can be installed quickly and reconfigured as production needs change.
Q1: What is the difference between a cleanroom and a sterile room?
A1: A cleanroom controls particulate contamination according to ISO classes, while a sterile room specifically addresses microbial contamination and is designed for aseptic processing. Sterile rooms must meet both particulate limits (ISO) and microbial limits (e.g., EU GMP Annex 1), and they require additional controls like sporicidal disinfection and media‑fill validation.
Q2: How often should a sterile room be re‑certified?
A2: HEPA filter integrity and particle counts should be tested at least annually (or more frequently for critical areas). Microbial monitoring is performed continuously during operation. A full re‑validation (including media fills) is typically required every 6–12 months, or after any major change to the facility or process.
Q3: What is the typical cost of building a sterile room?
A3: Costs vary greatly depending on size, classification, and complexity. A small ISO 7 (Grade C) modular room may start around $200,000, while a full‑scale aseptic filling suite (Grade A/B) can exceed $2–5 million. Factors include HVAC, materials, automation, and validation. TAI JIE ER provides detailed cost estimates based on user requirements.
Q4: Can a sterile room be used for both sterile and non‑sterile products?
A4: Cross‑contamination risk must be assessed. Generally, a room dedicated to sterile products is recommended. If shared use is unavoidable, rigorous cleaning validation and segregation in time (campaign manufacturing) with full cleaning between campaigns is required, along with risk assessment per regulatory guidelines.
Q5: What are the most common deficiencies found during sterile room inspections?
A5: Frequent observations include: inadequate personnel training and aseptic technique, poor documentation of cleaning and monitoring, insufficient pressure differentials, lack of sporicidal agent rotation, and failure to investigate excursions. A robust contamination control strategy (CCS) is now expected by regulators.
Q6: How do I choose between an isolator and a conventional cleanroom?
A6: Isolators provide a physical barrier, reducing contamination risk and allowing lower grade backgrounds (e.g., Grade C/D instead of Grade B). They are preferred for highly potent compounds or when operator protection is needed. Conventional cleanrooms are more flexible for large‑scale manual operations. The choice depends on product risk, throughput, and budget.
Q7: What is the role of a sterile room in hospital pharmacy?
A7: Hospital pharmacies use sterile rooms (often called cleanrooms) to prepare intravenous admixtures, chemotherapy drugs, and parenteral nutrition under USP 797 (sterile compounding) and USP 800 (hazardous drugs) standards. These rooms typically have ISO 5 areas within an ISO 7 buffer room, with negative pressure for hazardous drugs.
